By Market & Region

Filter fairsonline.org news by target market and region. Use the dropdown above to focus on the markets most relevant to your business.

Cherubic Ventures Closes $68.88M Fund VI, AUM Tops $500M

Taipei – September 04, 2026 -- Cherubic Ventures has closed its sixth fund at $68.88 million, pushing total assets under management across its six funds past $500 million.

Fund VI's Portfolio Companies Have Already Raised Over $500 Million in Follow-On Capital

Despite being early-stage, Fund VI's backed startups have collectively secured more than $500 million in subsequent funding rounds. The fund continues the firm's focus on AI-native companies spanning infrastructure, developer tools, enterprise software, healthcare, physical AI and robotics.

F&F Ventures, SHOPLINE Launch $10M Ecommerce Fund

Los Angeles – September 04, 2026 -- F&F Ventures has launched a $10 million fund with commerce platform SHOPLINE to back consumer brands from pre-seed through Series A, pairing capital with the operating infrastructure that serves more than 700,000 merchants globally.

Three operator-investors with prior exits lead the fund

General Partner Jeff Erickson scaled a consumer brand to eight figures before its sale to a private equity firm and has since made more than 40 angel investments. Co-Founder Adam Shaw grew a physical product company from zero to $18 million and led a seven-figure consumer goods brand, bringing global supply chain and private equity experience. General Partner Jian Tam is a serial CPG entrepreneur with multiple ecommerce exits and more than 20 years in the category, including as co-founder of ProteinWaffles.com.

IGEL Adds Teguar Hardware to Ready Ecosystem for Healthcare, Industrial Endpoints

Fort Lauderdale, Florida – September 04, 2026 -- IGEL has added Teguar to its IGEL Ready ecosystem, certifying the manufacturer's rugged and specialized hardware for use with IGEL OS in healthcare, manufacturing and warehouse settings.

Teguar brings purpose-built systems for environments unsuited to commercial-grade devices

Teguar's portfolio includes rugged, waterproof industrial computers alongside all-in-one systems and tablets designed for clinical use. The hardware targets operational conditions where standard commercial endpoints fail to meet durability or workflow requirements.

PTFE Membranes Market to Hit $2.84B by 2031, MarketsandMarkets Says

DELRAY BEACH, FLA. – September 04, 2026 -- The global PTFE membranes market is projected to reach $2.84 billion by 2031, up from $2.14 billion in 2026, expanding at a compound annual growth rate of 5.8%, according to MarketsandMarkets.

Asia Pacific commands 42.2% market share as region emerges fastest-growing

Asia Pacific accounted for 42.2% of the PTFE membranes market in 2026, driven by industrial expansion, pharmaceutical and biotechnology manufacturing, and semiconductor production across China, India, Japan, South Korea, and Southeast Asia. The region is also expected to post the fastest growth through 2031, as countries increase investment in advanced manufacturing, healthcare infrastructure, and water treatment capacity.

Mixx Unveils SxC Connector, Terminates 24,576 Fibers Per Rack Unit

SAN JOSE, Calif. – September 04, 2026 -- Mixx Technologies, Inc. has launched the SxCTM Connector, an optical connector capable of terminating up to 24,576 fibers in a single rack unit, a density the company says is four times greater than MMC-VSFF, the highest-density connector platform currently qualified for deployment.

Connector density becomes the bottleneck for co-packaged optics deployment

Mixx, a venture-backed deep-tech firm building co-packaged optics (CPO) for hyperscale AI infrastructure, said existing connector families cannot support the fiber density that next-generation inference workloads require. A 400T switch brings thousands of fibers out of a single box, exceeding what pluggable transceivers can support at the front panel. Mixture-of-experts and agentic AI workloads demand high radix — the number of endpoints a single node can reach — to minimize latency and reduce switching layers, transceivers, and cables.

Greenway Posts 38% Revenue Growth, Record Grams Sold in Q1 F2027

Kingsville, ON – September 04, 2026 -- Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) reported net revenue of CA$2.23 million for the three months ended June 30, 2026, up 38% from CA$1.62 million a year earlier, while grams sold hit a record 2.33 million, an 8% increase over the prior high.

Cash cost per gram falls 30% to CA$0.69 as production efficiency improves

The company generated CA$36,778 in cash from operating activities, reversing a cash outflow of CA$865,538 in the same quarter last year. Adjusted EBITDA came in positive at CA$47,900, even as net loss and comprehensive loss totaled CA$659,893. Gross margin before fair value adjustments narrowed to 12%, reflecting a lower average net sales price of CA$0.96 per gram, or CA$1.30 per gram excluding inventory tied to discontinued cultivars.

Info-Tech: Data Governance Stalls as Firms Buy Tools Over Decisions

Arlington – September 04, 2026 -- Some 72.5% of organizations are currently invested in data management solutions and plan to increase that spending, yet many governance programs remain fragmented and produce activity without measurable impact, according to Info-Tech Research Group.

Governance priority tops both AI and non-AI data agendas

Info-Tech's Future of IT 2026 Survey found that improving data governance ranked as the leading data priority for supporting AI goals, cited by 30% of respondents, and outside AI, cited by 40%. The research group says this points to a disconnect between heavy investment in management solutions and unresolved governance decisions needed to guide them.

Kazia Therapeutics Closes Oversubscribed Offering, Up to $120M Raised

Sydney – September 04, 2026 -- Kazia Therapeutics Limited (NASDAQ: KZIA) has closed an oversubscribed, tranched public offering that generated approximately $40 million in upfront gross proceeds, with total potential proceeds reaching approximately $120 million if milestone-linked warrants are fully exercised.

Offering priced above market with milestone-triggered warrant premiums

The combined offering price was set at $15.50 per American Depositary Share (ADS), with both warrant tranches priced at premiums to that level. Series A Warrants carry an exercise price of $17.825 per ADS, a 15% premium, tied to Kazia's Stage IV triple-negative breast cancer (TNBC) data readout expected in the second half of 2027. Series B Warrants carry an exercise price of $19.375 per ADS, a 25% premium, tied to the company's HR+/HER2- breast cancer data readout expected in the first half of 2028.

Cango Posts $81.6M Q2 Loss, Pivots to AI Compute Amid Mining Slump

Dallas – September 04, 2026 -- Cango Inc. (NYSE: CANG) reported a net loss of US$81.6 million for the second quarter of 2026, driven primarily by non-cash impairment and disposal charges on its Bitcoin mining fleet, as the company accelerates a pivot toward AI compute infrastructure.

Revenue halves as company right-sizes mining fleet

Total revenue fell approximately 50% sequentially to US$50.8 million, with US$47.4 million derived from Bitcoin mining and US$3.4 million from other sources. The decline stemmed from Cango's decision to phase out older S19-series mining machines and shift some capacity to a hosted leasing model, a move management said improved operating costs and cash flow despite the top-line hit.

SiMa.ai, ARK Electronics Launch US-Made Drone AI Bundles

San Jose, Calif. – September 04, 2026 -- SiMa.ai and ARK Electronics have launched the ARK-SiMa.ai Modalix MLSoC Bundles, a production-ready hardware-software package aimed at cutting development time for autonomous drones used in defense, agriculture, and commercial operations.

Joint platform pairs SiMa.ai compute with ARK Electronics drone hardware

The bundles combine SiMa.ai's Modalix System-on-Module, built on its Modalix MLSoC, with Palette Neat, an agentic development environment the company says compresses AI development timelines from months to days. ARK Electronics, a Salt Lake City-based maker of made-in-the-USA, NDAA-compliant, Blue UAS-listed flight controllers and embedded computers, built and validated the joint solution for the drone ecosystem.

Innocan Pharma Q2 Revenue Falls 25% to $5.25M on US Tariff Uncertainty

Herzliya, Israel – September 04, 2026 -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) reported second-quarter fiscal 2026 revenue of US$5.25 million (CAD 7.3 million), a 25.06% decline from US$7.01 million in the same period last year, as shifting U.S. customs and tariff policy under the Trump administration disrupted sales.

Gross margin holds above 90% despite revenue drop

Gross profit fell 23.0% to US$4.769 million, but gross margin remained elevated at 90.8% for the three months ended June 30, 2026, up from 88.4% a year earlier. The company attributed the resilience to its direct-to-consumer model and disciplined cost structure at consumer wellness subsidiary B.I. Sky Global Ltd., which it owns 60%.

Greenberg Traurig Hires Ex-Meta Counsel for Digital Infrastructure Practice

WASHINGTON – September 04, 2026 -- Greenberg Traurig, LLP has added Rose Schlichtmann-Prince as a shareholder in its Washington, D.C., and Miami offices, expanding its Digital Infrastructure Group as investment in data centers and fiber networks accelerates.

Former Meta Platforms counsel brings decade of network infrastructure experience

Schlichtmann-Prince joins after nearly ten years as in-house counsel at Meta Platforms, Inc., where she advised on network infrastructure investments and strategic initiatives supporting the company's global digital infrastructure platform. She previously held legal and business roles at Verizon Communications, Cable & Wireless Communications, and Sprint, bringing more than 15 years of combined private practice, in-house, and business operations experience.

Wellinks Names Ex-Teladoc COO, UConn Health CEO to Board

New Haven, Conn. – September 04, 2026 -- Wellinks, a virtual-first cardiopulmonary care company, has appointed Andrew Agwunobi, MD, MBA, and Mike Waters to its Board of Directors while adding three vice presidents to its management team, the company said.

Former Teladoc COO Mike Waters joins Wellinks board with digital health portfolio

Waters, who spent more than two decades in strategic operations and previously served as Chief Operating Officer of Teladoc Health, also brings 15-plus years from Providence Health, where he was Executive Vice President and Chief Executive of its Ambulatory Care Network. He currently holds board roles across six digital health companies, including Chair positions at Ieso and Brook Health.

UB Deploys 8 Electric Buses, Cutting Fleet Emissions 55.6%

Buffalo, N.Y. – September 04, 2026 -- The University at Buffalo has put eight new 40-foot battery-electric transit buses into service, marking the first phase of a diesel-to-electric transition for its Stampede fleet, which carries approximately 16,000 passengers daily.

Electrification of first eight buses is projected to cut 5,984 metric tons of CO2 equivalent

UB, transportation provider WeDriveU and fleet electrification specialist Zenobē estimate the shift will deliver a 55.6% reduction in greenhouse gas emissions compared with diesel-powered service, equivalent to removing roughly 1,395 cars from the road.

Qinghai-Xizang Railway Hits 824M Tonnes Freight in 20 Years

Xining, China – September 03, 2026 -- The Qinghai-Xizang Railway has moved 104 million passengers and more than 824 million tonnes of freight across its 1,956-kilometer route since opening 20 years ago, reshaping trade flows and industrial output on the Tibetan plateau.

Cold-chain rail link boosts herder incomes and potash exports

Xizang Gaerde Ecological Livestock Industry Development Co., Ltd. now uses railway cold-chain transport to move fresh milk from the Qiangtang grassland to markets nationwide, raising incomes for thousands of herder households. At Qarhan Salt Lake in Qinghai, potash fertilizer lines feed directly into rail terminals; more than four million tonnes of potash fertilizer moved by rail in 2025.

Sprintpackage Triples Output at New 20,000 SQM Guangzhou Plant

Guangzhou – September 03, 2026 -- Guangzhou Shangpin Packaging Products Co., Ltd. (Sprintpackage) has doubled to tripled its annual paper tube production output after relocating operations to a new 20,000-square-meter facility in the No. 1 Hard Technology Industrial Park, Baiyun District, Guangzhou, completed in June 2026.

Six automated lines push daily capacity to 300,000 units

The new plant runs six fully automated production lines covering tube winding, slitting, paper mounting, curling, and final assembly in-house. With automation exceeding 80%, Sprintpackage now produces between 200,000 and 300,000 tube units daily, supplying buyers primarily across Europe and the Middle East.

Lilly's Taltz-Zepbound Combo Sustains Gains at 52 Weeks

INDIANAPOLIS – September 03, 2026 -- Eli Lilly and Company reported that combining Taltz (ixekizumab) with Zepbound (tirzepatide) sustained or deepened efficacy at 52 weeks in patients with psoriatic disease and obesity, building on statistically superior results already seen at Week 36 versus Taltz alone.

Combination therapy nearly triples complete skin clearance response rates

In the TOGETHER-PsO trial, 30.6% of patients on the combination achieved PASI 100 plus at least 10% weight loss at Week 52, compared with 4.4% on Taltz monotherapy. Complete skin clearance alone (PASI 100) was maintained by 40.5% of combination patients versus 29.1% on monotherapy.

Jazz's Ziihera Shows Significant Survival Edge Over Trastuzumab in GEA Trial

Dublin – September 03, 2026 -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) reported that Ziihera (zanidatamab-hrii) combined with chemotherapy produced a statistically significant and clinically meaningful overall survival (OS) benefit versus trastuzumab plus chemotherapy in a second interim analysis of the Phase 3 HERIZON-GEA-01 trial in first-line HER2-positive gastroesophageal adenocarcinoma (GEA).

OS hazard ratio for Ziihera plus chemotherapy improved versus the first interim analysis

The company said the survival advantage strengthened compared with earlier data, reinforcing Ziihera's position following its FDA approval on August 25, 2026. No new safety signals emerged relative to previously reported HERIZON-GEA-01 data or the known profiles of the individual agents.

CHINT Unveils 1,000 kV Transformers, SF6-Free Grid Tech at CIGRE 2026

Paris – September 03, 2026 -- CHINT presented a portfolio of high-voltage transformers, SF6-free switchgear and data center power systems at CIGRE 2026, targeting Europe's grid operators as they contend with surging AI-driven electricity demand.

CHINT displays 1,000 kV and 750 kV transformer technology for high-voltage transmission

Under its Green Power Grid & High Voltage lineup, the company showcased 1,000 kV low-loss, low-noise oil-immersed power transformers alongside 750 kV natural ester oil-immersed units. It also presented SF6-free medium- and high-voltage switchgear, including 24 kV, 145 kV and 420 kV SF6-free gas-insulated switchgear (GIS), aimed at cutting environmental impact in grid infrastructure.

PVA Gathers 400+ Clinicians in Las Vegas for SCI/MS/ALS Care Summit

Las Vegas – September 03, 2026 -- Paralyzed Veterans of America (PVA) opened its 2026 Healthcare Summit + Expo at the Horseshoe Hotel, drawing more than 400 healthcare professionals to advance clinical care for spinal cord injury, MS, and ALS. The event runs through September 2 and features 110 speakers and 60 exhibitors, with remarks from Department of Veterans Affairs Secretary Doug Collins.

Summit connects 400 clinicians to close gaps in SCI/D care

PVA National President Robert Thomas said healthcare for veterans with traumatic spinal cord injuries and diseases like MS and ALS extends from research through rehabilitation and long-term community life. PVA, founded in 1946, is the only nonprofit Veterans Service Organization with access inside all 25 VA SCI/D Centers, a position that has shaped its 80-year investment in research, clinical education, and advocacy.